Clinical routine use of dopamine transporter imaging in 516 consecutive patients

Journal of Neurology

Volumn 262, Issue 4, 2015, Pages 909-915

  Thiriez, Claire ^a,b   Itti, Emmanuel ^a,c   Fénelon, Gilles ^a   Evangelista, Eva ^a   Meignan, Michel ^a,c   Cesaro, Pierre ^a,c   Remy, Philippe ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c FACULTÉ DE MÉDECINE   (France)

Author keywords

DaTSCAN; Parkinson s disease; SPECT; Tremor; 123I FP CIT

Indexed keywords

DOPAMINE TRANSPORTER; FP CIT I 123; IOFLUPANE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; TROPANE DERIVATIVE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DOPAMINE TRANSPORTER IMAGING; ESSENTIAL TREMOR; FEMALE; HUMAN; IN VIVO STUDY; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL SPECIALIST; MOLECULAR IMAGING; NEUROIMAGING; NEUROLOGIST; PARKINSON DISEASE; PARKINSONISM; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VERY ELDERLY; BRAIN; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MOTOR DYSFUNCTION; SCINTISCANNING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOVEMENT DISORDERS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; YOUNG ADULT;

EID: 84928332424     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7634-y     Document Type: Article

References (21)

1. Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson’s disease. Lancet Neurol 5:75–86
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
3. Meara J, Bhowmick BK, Hobson P (1999) Accuracy of diagnosis in patients with presumed Parkinson’s disease. Age Ageing 28:99–102
4. Sixel-Doring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C (2011) The role of (123)I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258:2147–2154
5. 123I]-FP-CIT study group. Mov Disord 15:503–510
6. 123I]β-CIT ‘Single-Photon Emission Computed Tomography Is Normal in Dopa-Responsive Dystonia. Ann Neurol 43:792–800
7. Schwingenschuh P, Ruge D, Edwards MJ et al (2010) Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson’s disease: a clinical and electrophysiological study. Mov Disord 25:560–569
8. Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y (2004) 123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Cerebrovascular Disease and Clinical Diagnosis of Vascular Parkinsonism. J Nucl Med 45:1688–1693
9. Benaderette S, Zanotti Fregonara P, Apartis E et al (2006) Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord 21:310–317
10. 123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson’s disease. Mov Disord 21:510–514
11. 123I]-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 15:1158–1167
12. Perju-Dumbrava LD, Kovacs GG, Pirker S et al (2012) Dopamine Transporter Imaging in Autopsy-Confirmed Parkinson’s Disease and Multiple System Atrophy. Mov Disord 27(1):65–71
13. Catafau AM, Tolosa E (2004) Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord 19:1175–1182
14. Tolosa E, Borght TV, Moreno E (2007) Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov Disord 22:2346–2351
15. Antonini A, Berto P, Lopatriello S, Tamma F, Annemans L (2008) And Chambers M. Cost- effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson’s disease in Italy. Mov Disord 23:2202–2209
16. Kas A, Payoux P, Habert MO et al (2007) Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP- CIT images. J Nucl Med 48:1459–1467
17. Lehnert BE (2010) Bree RL; Analysis of Appropriateness of Outpatient CT and MRI Referred From Primary Care Clinics at an Academic Medical Center: how Critical Is the Need for Improved Decision Support? J Am Coll Radiol 7:192–197
18. Kupsch A, Bajaj N, Weiland F et al (2013) Changes in clinical management and diagnosis following DaTscan™ SPECT imaging in patients with clinically uncertain Parkinsonian syndromes: a 12-week follow-up study. Neurodegener Dis 11:22–32
19. Van Laere K, Everaert L, Annemans L, Gonce M, Vandenberghe W (2008) Vander Borght T. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis parkinsonism. Eur J Nucl Med Mol Imaging 35:1367–1376
20. Dodel RC, Höffken H, Möller C et al (2003) Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson’s disease: a decision-analytic approach. Mov Disord 18(Suppl 7):S52–S62
21. Newman EJ, Breen K, Patterson J, Hadley DM, Grosset KA, Grosset DG (2009) Accuracy of Parkinson’s disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord 24:2379–2385